We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Robotic Surgery Facilitates Partial Nephrectomy

By HospiMedica staff writers
Posted on 11 Dec 2007
Robotic partial nephrectomy for patients with complex kidney tumors accomplishes tumor resection and renal reconstruction while minimizing warm ischemia times, claims a new study.

Researchers at the United States National Cancer Institute (NCI, Bethesda, MD, USA) assessed a total of 14 tumors that were resected by robotic partial nephrectomy from eight patients (mean age 50.3 years) with complex kidney tumor features, which included hilar, completely endophytic, or multiple tumors. More...


The results showed that the robotic partial nephrectomy procedures were performed successfully without complications. Hilar clamping was used with a mean warm ischemia time of 31 minutes; mean blood loss was 230 milliliters. Histopathology confirmed three cases of clear-cell renal cell carcinoma, two of hybrid oncocytic tumor, two chromophobe renal cell carcinomas, and an oncocytoma. Mean index tumor size was 3.6 cm, and all patients had negative surgical margins. At 3-months follow-up, no patients experienced a statistically significant change in serum creatinine or estimated glomerular filtration rate and there was no evidence of tumor recurrence. The study was published ahead of print on October 15, 2007, in the online version of European Urology.

"A robotic approach can facilitate the technical challenges of laparoscopic partial nephrectomy, potentially allowing select patients to receive a minimally-invasive and nephron-sparing surgery who might otherwise receive open surgery or total nephrectomy,” said first author Dr. Craig Rogers, director of robotic kidney surgery at Henry Ford Hospital (Detroit, MI, USA).


Related Links:
United States National Cancer Institute
Henry Ford Hospital

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Radiofrequency Generator
GX1
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.